Oragenics
OGEN
24 hedge funds and large institutions have $1.08M invested in Oragenics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
4% less funds holding
Funds holding: 25 → 24 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
56% less capital invested
Capital invested by funds: $2.48M → $1.08M (-$1.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.9K |
| 3 |
Renaissance Technologies
New York
|
+$10.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.77K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$6.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBF
Sara-Bay Financial
Sarasota,
Florida
|
-$145K |
| 2 |
Millennium Management
New York
|
-$24K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$20K |
| 4 |
Jane Street
New York
|
-$13K |
| 5 |
VF
Virtu Financial
New York
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $84 | – | – | – |
|
27
Morgan Stanley
New York
| $1 | – | – | – |
|
|
28
Millennium Management
New York
| – | -$24K | -60 | Closed |
|
|
29
HighTower Advisors
Chicago,
Illinois
| – | -$20K | -50 | Closed |
|
|
30
Jane Street
New York
| – | -$13K | -32 | Closed |
|
|
VF
31
Virtu Financial
New York
| – | -$7K | -17 | Closed |
|
|
GC
32
Grimes & Company
Westborough,
Massachusetts
| – | -$3K | -7 | Closed |
|
|
HF
33
HRT Financial
New York
| – | -$2K | -7 | Closed |
|
|
TFGT
34
TS Financial Group (TSFG)
Lake Forest,
Illinois
| – | -$1K | -2 | Closed |
|
OGEN Hedge Fund Activity: Q4 2022 in Review
24 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2022, worth a combined $1.08M — down 56% from $2.48M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of OGEN and 7 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $28.9K. The largest seller was Sara-Bay Financial, cutting an estimated $145K.
- 24 institutional investors held Oragenics (OGEN) as of Q4 2022, down from 25 in Q3 2022.
- Funds reported $1.08M of Oragenics stock for Q4 2022, down 56% quarter-over-quarter.
- 7 funds opened new Oragenics positions in Q4 2022 and 8 closed out, a net change of -1 holder.
- The largest Oragenics buyer in Q4 2022 was Susquehanna International Group, an estimated $28.9K added.
- The largest Oragenics seller in Q4 2022 was Sara-Bay Financial, an estimated $145K sold.
Based on aggregated 13F filings for Q4 2022.